Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Taurolidine Containing Lock Solution for Prevention of Central Venous Catheter Infection in ICU Patients

NCT07366372 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07366372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07366372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Taurolidine Containing Lock Solution for Prevention of Central Venous Catheter Infection in ICU Patients
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2023
Completion date
November 1, 2024
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central venous catheter infection, intensive care unit, lock solution, prevention, taurolidine